The shares are down 22%, or $15.71, to $55.94 in late-day trading.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRON:
- Disc Medicine down 32% to $49 after confirming rejection letter from FDA
- Disc Medicine confirms complete response letter from FDA for bitopertin
- Disc Medicine says issue raised by FDA ‘readily addressable’
- Disc Medicine extends decline after volatility halt
- Disc Medicine plunges after FDA posts complete response letter for bitopertin